Gotham City’s Criticism of Grifols Sparks Doubts Again
The entity led by Daniel Yu has raised concerns about Grifols once more through the social network X, following Brookfield’s withdrawal from the purchase deal. According to them, “Brookfield was not receiving the necessary information after reviewing Grifols’ books.” After a rough day in the stock market yesterday (losing over 10%), Grifols is also facing challenges today in the Spanish stock exchange. During the session, the pharmaceutical company has seen a steep decline in the stock market, dropping more than 10%.
Gotham’s attack is based on information published by Bloomberg, where the economic portal states that Brookfield was still waiting for the delivery of certain information related to the plasma-derived products company four months after announcing its intention to acquire 70% of the company. In fact, this request was already announced by the Canadian fund through a communication to the National Securities Market Commission, stating that in a letter sent to the pharmaceutical company on November 11, they had requested additional information as part of the due diligence process.
Gotham also hints on the same social network that this is not the first time that the Spanish company has been accused of lack of transparency. In fact, they recall that back in July, Moody’s withdrew its ratings on Grifols for not having the necessary information to assess the company’s debt.
Legal Proceedings
Gotham’s actions are also under scrutiny in the courts. The judge of the National Court, José Luis Calama, admitted a complaint from the Anticorruption Prosecutor’s Office to investigate Gotham City, General Industrial Partners LLP (GIP), and several of its executives
